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The subject of today's conference is pan- 
creatic tumors, more particularly, pan- 
creatic carcinoma. Each time I am asked to 
discuss carcinoma of the pancreas at this 
conference, I review tile interval literature 
and find it distressingly unchanged. 
Before presenting the more important  
features of pancreatic tumors I would like 
to paraphrase a short quotation by Dr. 
Warren which I think aptly describes the 
problem we face in dealing with this organ. 
Dr. Warren describes the pancreas as a com- 
plex and defiant organ, hidden in the up- 
per, deeper recesses of the abdomen where 
it cannot normally be palpated, intimately 
associated with the duodenum and biliary 
system and adjacent to the great abdominal 
vessels, tile stomach and the spleen. It 
presents an awesome challenge to the sur- 
geon; because it is related physiologically 
and biochemically to the other organs of 
digestion, it is important  for the mainte- 
nance of a healthy, well-nutritioned orga- 
nism; yet its functions are incompletely un- 
derstood (1). 
Many of us who have dealt with tumors 
of the pancreas have become discouraged 
with our inability to effect a great differ- 
ence in the course these patients pursue 
from the time they become symptomatic to 
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their ahnost inevitable demise. I think 
there are a number  of reasons for this 
which 1 hope to bring out along with some 
faint possibilities for improving our 
present experience. This is all the more 
important  because of the admittedly poorly 
documented but prevailing belief that the 
incidence of carcinoma of the pancreas is 
increasing. 
Figure 1 presents a classification of pan- 
creatic tumors, ahhough the exocrine neo- 
plasms are the ones with which we are 
concerned today. Endocrine tumors, arising 
in the islets or elsewhere in the gland, have 
been tile subject of other conferences and 
will not be discussed at this time. Support- 
ing tissue tumors also occur in the pan- 
creas but are extremely uncommon.  T h e  
exocrine neoplasms arise either in the acini 
or are of duct-cell origin and the common, 
Fig 1. Classification of pancreatic tumors. 
I. Exocrine neoplasms 
A. Acinar cells 
1. Adenomas (rare) 
2. Adenocarcinomas (rare) 
B. Duct cells 
1. Benign 
a. Solid adenoma (rare) 
b. Cystadenoma (rare) 
2. Malignant 
a, Solid carcinoma 
(1) Adenocarcinoma (common) 
(2) Anaplastic carcinoma (uncommon) 
(3) Squamous celt carcinoma (rare) 
b. Cystadenocarcinoma (rare) 
II. Endocrine neoplasms 
Ill. Supporting tissue tumors 
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garden-variety carcinoma of the pancreas is 
an adenocarcinoma arising fro,n ductular  
epithelium. Duct-cell neoplasms are usually 
solid tmnors but  occasionally may be cystic. 
These cystadenomas and cystadenocarcino- 
mas, while uncommon,  present sufficiently 
distinctive features (2), differing in their 
management  from either pseudocysts or 
solid tumors to warrant  at least brief con- 
sideration. They  occur more frequently in 
females by a rat io of approximate ly  9 to 1, 
whereas solid tumors are more commonly 
encountered in males. Most patients with 
cystic tumors are over the age of 50 and 
present with relatively few symptoms. Such 
neoplasms are usually encountered as a 
nontender,  palpable  mass in the left upper  
quadran t  or the upper,  m idabdomen  in a 
pat ient  with mild, ill-defined abdominal  
discomfort, I t  is impor tan t  to ascertain 
insofar as possible that the pat ient  has not 
had pancreatit is  or experienced abdominal  
t rauma which would predispose to pseu- 
docyst formation.  A rapid  change in size of 
a previously recognized cystic lesion sug- 
gests that one is more likely dealing with a 
neoplastic cyst. Surgical explorat ion should 
be under taken  in an individual  suspected 
of having a neoplastic c)st, and resection 
ra ther  than marsupial izat ion carried out. 
T h e  latter procedure is associated with a 
significant recurrence rate and is obviously 
not satisfactory t reatment  for a cystadeno- 
carcinoma. 
Now what about  the more common solid 
tumors of duct-cell origin? These occur 
twice as frequently in male patients, whose 
mean age is 55 )'ears. In two-thirds of the 
cases the head of the pancreas is the site; 
the body and tail contr ibute  approximate ly  
(Ze 20°/..0 and 10o ,  rest)ectively. Th ree  factors 
have been discussed in the l i terature as 
possible predisposing influences. Needless 
to say, in the major i ty  of patients, such 
factors are not clearly evident. Some have 
felt that chronic pancreatit is constitutes 
one such condition but the evidence is 
conflicting and highly circumstantial. Dia- 
betes mellitus has been similarly regarded 
(3), but it is often difficult to know if the 
abnormal i ty  in glucose tolerance has 
preceded the tumor or has developed as a 
consequence of it. Indirect  support  for this 
view is provided by the observation that 
ductular  hyperplasia is frequent in both 
diabetics and in patients with pancreatic 
carcinoma. In some, hyperplasia has been 
observed to merge with in situ and invasive 
carcinoma, a si tuation reminiscent of, but 
no more enlightening than, that occurring 
in rectal polyps. A prel iminary retrospec- 
tive study has further suggested that pa- 
tients who develop carcinoma of the pan- 
creas consume larger amounts  of alcohol 
than those who do not (4). However, the 
relat ionship of chronic pancreatitis, heavy 
alcohol consumption and diabetes mellitus 
to the origin of carcinoma of the pancreas 
appears to be tenuous, at best, and for the 
present must be regarded as unclear. 
Everyone is familiar with the classic triad 
of pain, jaundice and weight loss which 
represent relatively late symptoms of pan- 
creatic carcinoma, ahnost always heralding 
an early death. Our  efforts to recognize 
early symptoms in these patients are ham- 
pered by the fact that only 15~, consult a 
physician within the first n-onth after the 
onset of symptoms, and only 65~.~ do so 
within 6 months. T h e  importance of this 
observation is underscored by Sato et al (5) 
who found that 56{~) of carcinolnas of the 
head of the pancreas were resectable when 
symptoms had been present for less than 3 
months, 1)ut only 13~,, when symptoms 
existed for a greater length of time. 
Many patients initially display rather 
vague and ill-defined symptoms that either 
do not occasion personal concern or arouse 
suspicion in the mind of the physician. 
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Although painless jaundice occurring in an 
older patient is highly suggestive of car- 
cinoma of the pancreas, this tumor, in the 
majority ot instances, is initially character- 
ized by abdomi,lal pain without jaundice. 
Tumors  arising in the head of the pancreas 
as a rule eventually produce jaundice 
which, in most instances, is preceded by not 
more than a [ew weeks of abdominal  pain. 
Pain, although not always severe, is charac- 
teristically persistent or recurrent and pro- 
gressive. These tumors which tend to 
infiltrate along nerve trunks and ducts are 
associated with a desmoplastic response. 
They  tend less to displace nerves, ducts and 
blood vessels than to envelop and encase 
them. This feature may account for the 
severe and unremit t ing pain these patients 
eventually experience. Although there are 
exceptions, the patient who has experi- 
enced abdonfinal pain from a carcinoma 
arising in the head of the pancreas will in 
general become jaundiced within 3 months 
of the onset of pain. For tumors arising in 
the body or tail, jaundice may never super- 
vene; if it does, it will generally do so after 
a much longer interval of discomfort. It  is 
worth reinembering that pain of pancreatic 
origin tends to localize in tim correspond- 
ing area of tim abdomen. Thus  tumors 
located in the head will produce more 
intense pain in the right epigastrium, 
whereas those located in the body will tend 
to localize to the midline, and those occur- 
ring in the tail may rel'er to tile left upper  
quadrant.  Tumors  arising in the tail may 
be the most difficult to diagnose (6) since 
they seldom produce jaundice, and usually 
lead to left upper  quadrant  or left midab- 
dominal pain which is often not suspected 
to be of pancreatic origin. Tumors  in this 
location may obstruct the splenic vein, 
leading to splenomegaly and hypersplen- 
ism; may obstruct the portal vein and pro- 
duce esophageal varices; or may obstruct 
the splenic artery, resulting ill all arterial 
I)ruit in tile left ul)per quadrant.  Such 
bruits, however, must be interpreted with 
caution since they lnay occur with a very 
large spleen regardless of cause, ar- 
teriovenous fistulas, splenic artery aneu- 
rysms and arteritis. 
In the jaundiced patient, a palpable gall- 
bladder has been emphasized as signifying 
extrahepatic biliary obstruction by tumor 
rather than calculus. This  is not invarial)ly 
true. Furthermore,  many otherwise palpa- 
ble gallbladders are missed because of fail- 
ure to search carefully in the proper  loca- 
tion. As the gallbladder distends and the 
liver enlarges as a result of biliary obstruc- 
tion, the fundus of the gallbladder is dis- 
1,lacel inferiorly and laterally and there- 
fore may be found far removed from its 
expected location. 
A number  of less common clinical 
features associated with pancreatic carcino- 
ma are presented in Fig 2. Hypoglycemia, 
although a rare manifestation of these tu- 
nlors, is ahnost invariably associated with 
complete obstruction of the main pan- 
creatic duct. 
Much has been written concerning the 
relationship of migratory thrombophlebit is  






Hypercalcemia (8, 9) 
Psychiatric changes (10) 
Depression with crying spells 
I ntractable insomn ia 
Anxiety 
Premonition of serious illness 
Carcinoid syndrome 
Subcutaneous fat necrosis (11) 
Portal hypertension 
Splenomegaly and hypersplenism 
Left upper quadrant arterial bruit 
Inappropriate~. ADH secretion (12) 
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and pancreatic carcinoma. Such an associa- 
tion is probably  not novel but  is likely to 
be a feature of many  int ra-abdominal  
malignancies resuhing in debil i tat ion and 
prolonged bed rest. T h e  same interpreta- 
t ion can be appl ied to so-called marant ic  
endocarditis and arterial embolization. Hy- 
percalcemia has been repor ted with duct- 
cell carcinomas but  it is not entirely clear 
that  such tumors are not  actually of islet- 
cell origin or carcinoid in type. Similarly, 
the carcinoid syndrome, a l though ascribed 
to sonle cases of duct-cell carcinoma, proba- 
bly occurs only with carcinoid tumors 
which have arisen in the pancreas. 
Psychiatric changes are difficult to char- 
acterize and quant i ta te  but  appear  to occur 
more frequently in association with car- 
c inoma of the pancreas than other malig- 
nant  lesions of the digestive tract. When  
associated with otherwise vague abdominal  
symptoms, these changes should direct at- 
tention to this organ. 
Subcutaneous fat necrosis, appear ing  as 
tender, subcutaneous nodules originat ing 
on the lower extremities and later involv- 
ing other portions of the body, is accom- 
panied by polyarthralgia  and a modest  
per ipheral  eosinophilia. Al though uncom- 
mon, such lesions have been found only 
with the rarer  acinar-cell carcinomas. These  
tumors have an extremely high lipase con- 
tent which in some way is probably  respon- 
sible. 
Unfor tunate ly ,  the clinical laboratory 
has been of l imited usefulness in the diag- 
nosis of carcinoma of the pancreas, T h e  
most frequently observed abnormal i ty  is a 
decrease in glucose tolerance which occurs 
in from 20 to 50% of cases. This  will be 
most readily recognized if a glucose 
tolerance test is carried out, ra ther  than 
depending on glucosuria or fasting hyper- 
glycemia. T h e  cause remains obscure and 
cannot  be related to extent  of replacement  
of the normal  pancreas by tumor. T h e  re- 
cent appearance of diabetes in a patient 
wi thout  a genetic predisposition, when ac- 
companied by abdominal  complaints, should 
call for a thorough investigation. An unex- 
plained increase in insulin requirement  in 
an established diabetic with gastrointestinal 
symptoms should be similarly regarded. 
A few patients may exhibit  minor  rises in 
serum or, more particularly, in urinary 
amylase values. Such changes are probably 
related to ductal obstruction and associated 
pancreatit is and have little diagnostic 
value. 
Ti le  use of pancreozymin-secretin prepa- 
rations to measure pancreatic reserve may 
have some value in localizing otherwise 
vague abdominal  symptoms to the pancreas 
without  revealing their exact cause. The  
differentiation between pancreatitis and 
carcinoma, while sometimes possible, is of- 
ten imprecise. In  some hands the concur- 
rent  examinat ion  of duodenal  contents for 
mai ignant  cells has been helpful  ( t3) ,  posi- 
tive results varying between 20 and 70(}0 in 
proven cases. For reasons that are not clear 
to me, we have never been particularly 
successful with this technic in our  own 
laboratory.  Much depends on the compe- 
tence of the cytologist but  even more on 
tim facility with which the specimens are 
collected and  processed. 
Pancreatic scanning technics are relative- 
ly recent additions to our diagnostic ap- 
proach but  tend to fall heir to the same 
limitations a t tending secretory tests, name- 
ly, the frequent  inabili ty to differentiate 
tumor  from areas of pancreatitis and cyst 
formation.  
This  brings us to a consideration of 
radiographic  procedures which, I think, 
currently constitute the most useful diag- 
nostic approach to pancreatic neoplasms. 
T h e  three technics which are applicable 
include bar ium contrast examinat ion of 
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the stomach and duodenum, selective arteri- 
ography and percutaneous cholangiogra- 
phy. In regard to the first of these, we are 
not interested in the widened and grossly 
distorted duodenal  loop classically associ- 
ated with carcinoma of the head of the 
pancreas, which almost invariably signifies 
an incurable if not inoperable lesion. 
Rather, we are interested in small areas of 
nodularity along the medial aspect of the 
duodenal sweep, or distortion and efface- 
ment of the duodenal folds in this region. 
The  ability to detect relatively minor  chan- 
ges of this type may be enhanced by the use 
of hypotonic duodenography.  One must be 
cognizant, however, of the fact that similar 
changes in the duodenogram may be pro- 
duced by chronic pancreatitis or collateral 
circulation associated with portal hyperten- 
sion from other causes. 
Of more value, I think, in defining pan- 
creatic lesions including carcinomas is se- 
lective arteriography. T h e  incidence of an- 
giographic abnormalities in proved cases 
ranges from 90% in a retrospective analysis 
by Lunderquist  to 29% in a prospective 
analysis by Nebesar and Pollard. T h e  ex- 
perience of Bookstein, Reuter  and Martel 
(14) at the University of Michigan and 
Wayne County Hospital  is, however, gener- 
ally encouraging. Prospective diagnoses 
were correct in 75% of carcinoma cases, in 
none of which was a completely normal 
arteriogram present. False positives oc- 
curred at a rate of 3%. Chronic pancreati- 
tis offers the most difficulty for the angiog- 
rapher, and in this group alone the false 
positive rate is likely to be highest. T h e  
authors indicate that irregular encasement, 
pathologic vessels and occlusion of large 
arteries are the most reliable signs of car- 
cinoma. They  further point  out  that opti- 
mal technic is vital, and superselective in- 
jections are often indispensable. 
One might imagine that such angiograph- 
ic abnormalities would be associated with 
a higher incidence of metastases, thereby 
heralding a more dismal prognosis and pro- 
viding no really useful information.  This  
possibility remains undetermined al though 
the experience of Sato et al (5) points to a 
high likelihood of nonresectability when 
abnormalities of the common hepatic or 
gastroduodenal artery are demonstrated. 
For the jaundiced pat ient  in whom the 
responsible lesion cannot  be localized to an 
intra- or extrahepatic site, percutaneous 
cholangiography may be helpful. T h e  pa- 
tient must be scheduled for celiotomy, 
since, in the event a dilated ductal system is 
found, explorat ion and relief of the ob- 
struction are imperative. If an extrahepatic 
obstruction cannot be demonstrated, the 
patient  is re turned to his bed and a percu- 
taneous liver biopsy is performed. While 
not a so-called routine procedure, it may be 
of considerable usefulness to the patient in 
whom the differentiation lies between ex- 
trahepatic obstruction (as from a pan- 
creatic tumor) and intrahepatic cholestasis 
(especially that which is drug-induced).  
Confirmation of the diagnosis of carcino- 
ma of the pancreas remains surgical. When  
resection is carried out, the pathologist will 
of course provide a definite answer in the 
majority of instances. In the absence of 
resection, the internist must depend upon 
the visual and tactile skills of the surgeon 
for an impression. Quite naturally, this will 
vary widely. Biopsy has generally been dis- 
couraged on the grounds that it will either 
result in tumor spread or predispose to a 
high frequency of serious complications. 
Neither  view is as well founded as many 
of us have been led to believe (15); per- 
haps biopsy should be under taken more 
often when the gross impression is doubtful  
and resection is not contemplated. 
Although treatment of pancreatic car- 
cinoma continues to be unsatisfactory, an 
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addit ional  reason for under taking a vigor- 
ous diagnostic approach is the possibility 
that some patients suspected of having car- 
cinonla of the pancreas may, in fact, have 
per iampul lary  tumors possessing a far bet- 
ter prognosis. T u m o r s  arising in the am- 
pulla, distal bile duct or duodenum have a 
5-year survival of 35-40~ o, about  4-5 times 
that for carcinoma of the pancreas. 
lake the final diagnosis, t reatment  re- 
mains largely the province of the surgeon. 
Unfortunately,  the overall resectability rate 
for carcinomas of tire head does not exceed 
25~7"o at best, and is even lower for tuntors 
of the body and tail. T h e  5-year survival 
[or all tumors whether  resectable or not is 
1 :o. For those in whom probably less than or 
a pancreaticoduodenectomy is possil)le, this 
figure becomes 7~*~ (16). This  procedure is 
generally regarded as carrying a mortal i ty  
of at least 10~: o al though Warren  et al have 
reported a figure of 2.9v~; ( I ) .  One might  
logically wonder, therefore, about  the ben- 
efits to be derived front operative interven- 
tion ira these patients. Apar t  fi-om the possi- 
bility that a small num be r  of patients can, 
in fact, be cured, and other more readily 
treatable periantpullary tumors discovered, 
significant pall iat ion through the relief of 
pruri tus  or vomit ing  is a worthwhile ol)jec- 
tive. Unfortunately,  tire mean survival after 
radical surgery is 15 nmnths, again em- 
phasizing ot,r inabili ty to prolong life in 
the majori ty  of individuals with this lesion. 
In  this discussion I have endeavored to 
point  out  some of the more useful and 
unusual  clinical features of carcinoma of 
the pancreas, as well as the diagnostic 
procedures currently available. I t  must  be 
emphasized that all diagnostic studies, 
while of assistance in proving that  the 
pat ient  has a pancreatic carcinoma, are of 
little or no help in establishing this early 
enough to improve prognosis. At present, I 
think we must content  ourselves with exer- 
cising a keen index of suspicion ill patients 
with wRgue ul)per abdominal  symptoms, 
particularly when associated with some of 
the more subtle and unusual features dis- 
cussed. A more liberal and prompt  recourse 
to hypotonic  duodenography and selective 
arteriography, while not guaranteeing a 
significant change in prognosis, may restdt 
in an increased likelihood of cure in some 
individuals. Although not assming a more 
favorable outcome, earlier diagnosis must 
derive from an emphasis on early and 
minimal  symptoms and less restricted 
recourse to abdominal  exploration.  
Dr. Pinedo: From what you said, I 
gather that there is no diagnostic 
procedm'e that can differentiate between 
pancreatit is and carcinoma with certainty. 
Dr. Watson: In general, that is true. 
T h e  definitive diagnosis is most frequently 
made after laparotomy. Selective arteriog- 
raphy, particularly with further experi- 
ence, may prove a welcome exception, how- 
ever. Unfor tunate ly  the more informative 
the evidence, the more advanced the tumor 
and the less chance of cure. Early surgical 
explorat ion is to be emphasized. 
Dr. Kuipcr: In those patients who are 
iuol~erable, would }ou use a chemothera- 
peutic agent? 
Dr. IVatso~: Present experience indi- 
cates that chemotherapy has relatively little 
or nothing to oller the patient with inoper- 
al)le pancreatic carcinoma either in terms 
of increased survival or l)alliation, ht re- 
spect to pain, we have I)een impressed 1)y 
tim ability of salicylates or Darvon to 
provide relief in excess of that which might 
be expected on the basis of narcotic re- 
quirements.  T h e  regular use of these medi- 
cations is often helpful in reducing o r  even 
e l iminat ing the need lor narcotics. 
l)r. Kau/man:  I just want to ask you 
whether you would regartl the presence of 
back pain as an index of inoperabili ty since 
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this migh t  i m p l y  i n v o l v e m e n t  of pos t e r io r  
sonlat ic  nerve roots.  
Dr. Watson: I w o u l d  have to say no. 
I m p i n g e m e n t  r a the r  than  in f i l t r a t i on  
migh t  p roduce  1)ain. 
Dr. Pinedo: T h e r e  are a s ignif icant  
n u m b e r  of pa t ien t s  wi th  a b d o m i n a l  pa in  
who have n o r m a l  1)arium studies  a n d  in 
whom it is not  possil)le to a r r ive  at  a 
d iagnosis  of panc rea t i c  disease. D o  you 
t h i n k  we shou ld  do a r t e r i og rams  in all  such 
pat ients?  
Dr. Watson: Cel-tainly c l in ica l  .iudge- 
men t  mus t  be exercised in o r d e r i n g  a r te r io -  
grams. I be l ieve  they shou ld  be u t i l i zed  
more  extens ive ly  than  is p resen t ly  the  case, 
especial ly  in pa t ien t s  e x h i b i t i n g  one  or  
more  of tile features  p rev ious ly  discussed.  
Wel l ,  our  t ime is u p  bu t  I t h i n k  o u r  
discussion today has at  least  emphas i zed  the 
p rob lems  we face in t ry ing  to dea l  wi th  
pancrea t i c  neoplasms,  a n d  I hope  i t  has  
l ) rovided some persl)ect ive which  m a y  be 
useful ill the i r  d iagnosis  and  m a n a g e m e n t .  
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